MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value ($000): $422,223 (100.0% shares, 0.0% debt)

Holdings (38)

CGEM Cullinan Oncology, Inc. 23.2%

Value ($000) $98,051 Shares 7,648,268 Est. Cost $40.60 Unrealized -66.8%

— iTeos Therapeutics, Inc. 7.9%

Value ($000) $33,260 Shares 1,745,943 Est. Cost $24.67 Unrealized —

— Inhibrx, Inc 5.4%

Value ($000) $22,976 Shares 1,279,995 Est. Cost $12.67 Unrealized —

— Verve Therapeutics, Inc 5.2%

Value ($000) $21,839 Shares 635,792 Est. Cost $34.35 Unrealized —

NTLA Intellia Therapeutics, Inc. 5.0%

Value ($000) $20,952 Shares 374,409 Est. Cost $95.88 Unrealized -35.3%

— Repare Therapeutics, Inc. 4.7%

Value ($000) $19,891 Shares 1,639,849 Est. Cost $31.02 Unrealized —

GERN Geron Corporation 4.7%

Value ($000) $19,709 Shares 8,422,582 Est. Cost $1.34 Unrealized +66.8%

— Iveric Bio Inc 4.5%

Value ($000) $18,837 Shares 1,050,000 Est. Cost $17.94 Unrealized —

— Merus N.V. 4.4%

Value ($000) $18,394 Shares 918,310 Est. Cost $17.60 Unrealized —

RGNX REGENXBIO Inc. 3.9%

Value ($000) $16,362 Shares 619,083 Est. Cost $29.67 Unrealized 0.0%

IOVA Iovance Biotherapeutics Inc 3.9%

Value ($000) $16,286 Shares 1,700,000 Est. Cost $12.64 Unrealized -8.8%

HOWL Werewolf Therapeutics, Inc. 2.6%

Value ($000) $10,770 Shares 2,388,011 Est. Cost $13.70 Unrealized -60.4%

— G1 Therapeutics, Inc. 2.5%

Value ($000) $10,701 Shares 856,798 Est. Cost $25.71 Unrealized —

CYTK Cytokinetics Inc. 2.2%

Value ($000) $9,361 Shares 193,205 Est. Cost $29.44 Unrealized +63.5%

BCRX Biocryst Pharmaceuticals Inc. 1.8%

Value ($000) $7,631 Shares 605,663 Est. Cost $15.77 Unrealized -18.4%

CRNX Crinetics Pharmaceuticals Inc. 1.7%

Value ($000) $7,163 Shares 364,710 Est. Cost $21.72 Unrealized -6.1%

TVTX Travere Therapeutics Inc. 1.6%

Value ($000) $6,812 Shares 276,460 Est. Cost $18.37 Unrealized +40.6%

— Y Mabs Therapeutics, Inc. 1.5%

Value ($000) $6,398 Shares 443,702 Est. Cost $30.56 Unrealized —

— TCR2 Therapeutics, Inc. 1.4%

Value ($000) $6,068 Shares 3,370,982 Est. Cost $14.28 Unrealized —

HRMY Harmony Biosciences Hldgs Inc. 1.4%

Value ($000) $6,058 Shares 136,780 Est. Cost $32.20 Unrealized +51.5%

ARQT Arcutis Biotherapeutics inc 1.2%

Value ($000) $4,915 Shares 257,185 Est. Cost $16.92 Unrealized +33.9%

— Reata Pharmaceuticals Inc 1.1%

Value ($000) $4,500 Shares 179,058 Est. Cost $32.76 Unrealized —

FOLD Amicus Therapeutics Inc. 1.0%

Value ($000) $4,102 Shares 392,946 Est. Cost $10.23 Unrealized +8.9%

— Provention Bio Inc 0.8%

Value ($000) $3,332 Shares 740,344 Est. Cost $4.10 Unrealized —

— Harpoon Therapeutics, Inc. 0.7%

Value ($000) $3,101 Shares 3,196,707 Est. Cost $14.79 Unrealized —

EWTX Edgewise Therapeutics, Inc. 0.7%

Value ($000) $2,992 Shares 304,027 Est. Cost $10.10 Unrealized 0.0%

MDGL Madrigal Pharmaceuticals Inc 0.7%

Value ($000) $2,908 Shares 44,747 Est. Cost $73.50 Unrealized -5.5%

RVMD Revolution Medicines, Inc. 0.7%

Value ($000) $2,880 Shares 146,041 Est. Cost $29.11 Unrealized -24.5%

— Verastem, Inc. 0.7%

Value ($000) $2,758 Shares 3,244,650 Est. Cost $2.94 Unrealized —

PHAT Phathom Pharmaceuticals Inc 0.5%

Value ($000) $2,142 Shares 193,326 Est. Cost $16.15 Unrealized -41.0%

— Avadel Pharmaceuticals Plc 0.5%

Value ($000) $2,066 Shares 412,363 Est. Cost $9.53 Unrealized —

MIRM Mirum Pharmaceuticals Inc. 0.5%

Value ($000) $2,045 Shares 97,322 Est. Cost $16.26 Unrealized +48.0%

— Oncorus, Inc. 0.5%

Value ($000) $2,020 Shares 2,377,031 Est. Cost $32.33 Unrealized —

— Inozyme Pharma Inc. 0.4%

Value ($000) $1,772 Shares 661,144 Est. Cost $7.80 Unrealized —

ADCT ADC Therapeutics, Inc. 0.4%

Value ($000) $1,612 Shares 334,384 Est. Cost $33.59 Unrealized -78.4%

— ESSA Pharma, Inc. 0.2%

Value ($000) $738 Shares 405,700 Est. Cost $8.00 Unrealized —

— AVROBIO, Inc. 0.1%

Value ($000) $416 Shares 647,918 Est. Cost $5.58 Unrealized —

BDTX Black Diamond Therapeutics, Inc. 0.1%

Value ($000) $405 Shares 239,888 Est. Cost $9.87 Unrealized -68.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGEM	Cullinan Oncology, Inc.	7,648,268	$98,051	23.2%	$40.60	-66.8%	Common	230031106
—	iTeos Therapeutics, Inc.	1,745,943	$33,260	7.9%	$24.67	—	Common	46565G104
—	Inhibrx, Inc	1,279,995	$22,976	5.4%	$12.67	—	Common	45720L107
—	Verve Therapeutics, Inc	635,792	$21,839	5.2%	$34.35	—	Common	92539P101
NTLA	Intellia Therapeutics, Inc.	374,409	$20,952	5.0%	$95.88	-35.3%	Common	45826J105
—	Repare Therapeutics, Inc.	1,639,849	$19,891	4.7%	$31.02	—	Common	760273102
GERN	Geron Corporation	8,422,582	$19,709	4.7%	$1.34	+66.8%	Common	374163103
—	Iveric Bio Inc	1,050,000	$18,837	4.5%	$17.94	—	Common	46583P102
—	Merus N.V.	918,310	$18,394	4.4%	$17.60	—	Common	N5749R100
RGNX	REGENXBIO Inc.	619,083	$16,362	3.9%	$29.67	0.0%	Common	75901B107
IOVA	Iovance Biotherapeutics Inc	1,700,000	$16,286	3.9%	$12.64	-8.8%	Common	462260100
HOWL	Werewolf Therapeutics, Inc.	2,388,011	$10,770	2.6%	$13.70	-60.4%	Common	95075A107
—	G1 Therapeutics, Inc.	856,798	$10,701	2.5%	$25.71	—	Common	3621LQ109
CYTK	Cytokinetics Inc.	193,205	$9,361	2.2%	$29.44	+63.5%	Common	23282W605
BCRX	Biocryst Pharmaceuticals Inc.	605,663	$7,631	1.8%	$15.77	-18.4%	Common	09058V103
CRNX	Crinetics Pharmaceuticals Inc.	364,710	$7,163	1.7%	$21.72	-6.1%	Common	22663K107
TVTX	Travere Therapeutics Inc.	276,460	$6,812	1.6%	$18.37	+40.6%	Common	89422G107
—	Y Mabs Therapeutics, Inc.	443,702	$6,398	1.5%	$30.56	—	Common	984241109
—	TCR2 Therapeutics, Inc.	3,370,982	$6,068	1.4%	$14.28	—	Common	87808K106
HRMY	Harmony Biosciences Hldgs Inc.	136,780	$6,058	1.4%	$32.20	+51.5%	Common	413197104
ARQT	Arcutis Biotherapeutics inc	257,185	$4,915	1.2%	$16.92	+33.9%	Common	03969K108
—	Reata Pharmaceuticals Inc	179,058	$4,500	1.1%	$32.76	—	Common	75615P103
FOLD	Amicus Therapeutics Inc.	392,946	$4,102	1.0%	$10.23	+8.9%	Common	03152W109
—	Provention Bio Inc	740,344	$3,332	0.8%	$4.10	—	Common	74374N102
—	Harpoon Therapeutics, Inc.	3,196,707	$3,101	0.7%	$14.79	—	Common	41358P106
EWTX	Edgewise Therapeutics, Inc.	304,027	$2,992	0.7%	$10.10	0.0%	Common	28036F105
MDGL	Madrigal Pharmaceuticals Inc	44,747	$2,908	0.7%	$73.50	-5.5%	Common	558868105
RVMD	Revolution Medicines, Inc.	146,041	$2,880	0.7%	$29.11	-24.5%	Common	76155X100
—	Verastem, Inc.	3,244,650	$2,758	0.7%	$2.94	—	Common	92337C104
PHAT	Phathom Pharmaceuticals Inc	193,326	$2,142	0.5%	$16.15	-41.0%	Common	71722W107
—	Avadel Pharmaceuticals Plc	412,363	$2,066	0.5%	$9.53	—	Common	05337M104
MIRM	Mirum Pharmaceuticals Inc.	97,322	$2,045	0.5%	$16.26	+48.0%	Common	604749101
—	Oncorus, Inc.	2,377,031	$2,020	0.5%	$32.33	—	Common	68236R103
—	Inozyme Pharma Inc.	661,144	$1,772	0.4%	$7.80	—	Common	45790W108
ADCT	ADC Therapeutics, Inc.	334,384	$1,612	0.4%	$33.59	-78.4%	Common	H0036K147
—	ESSA Pharma, Inc.	405,700	$738	0.2%	$8.00	—	Common	29668H708
—	AVROBIO, Inc.	647,918	$416	0.1%	$5.58	—	Common	05455M100
BDTX	Black Diamond Therapeutics, Inc.	239,888	$405	0.1%	$9.87	-68.8%	Common	09203E105